Search

Gerresheimer AG

Abrir

SetorSaúde

66.45 -2.21

Visão Geral

Variação de preço das ações

24h

Atual

Mín

64.75

Máximo

69.4

Indicadores-chave

By Trading Economics

Rendimento

11M

38M

Vendas

70M

569M

P/E

Médio do Setor

22.028

63.778

EPS

1.63

Rendimento de Dividendos

1.71

Margem de lucro

6.731

Funcionários

12,142

EBITDA

16M

117M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+49.53% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.71%

2.39%

Próximos Ganhos

11 de abr. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-382M

2.4B

Abertura anterior

68.66

Fecho anterior

66.45

Sentimento de Notícias

By Acuity

16%

84%

28 / 386 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Gerresheimer AG Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

13 de mai. de 2024, 11:16 UTC

Principais Notícias

German Companies Bet on AI But Payoff Could Be Years Away -- Talking Markets

Gerresheimer AG Previsão

Preço-alvo

By TipRanks

49.53% parte superior

Previsão para 12 meses

Média 102.73 EUR  49.53%

Máximo 122.5 EUR

Mínimo 93 EUR

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para Gerresheimer AG - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

13 ratings

12

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

67.9 / 74.9Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

28 / 386 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.